US$ 26.16
tirzepatide 15 mg reconstitution (15mg Vial) 40 mg tirzepatide reconstitution How
Description
Endocr Rev 2008;29:36779.PubMedPMC 34
Zepbound (tirzepatide) for Weight Management : Approved in November 2023 for chronic weight management in adults with a body mass index (BMI) of 30 kg/m or greater (obesity), or 27 kg/m or greater (overweight) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia

Some patients assume the goal is always the highest dose

Prioritize getting 7-9 hours of quality sleep per night
